145 related articles for article (PubMed ID: 33422073)
21. Dual responsive micelles capable of modulating miRNA-34a to combat taxane resistance in prostate cancer.
Lin F; Wen D; Wang X; Mahato RI
Biomaterials; 2019 Feb; 192():95-108. PubMed ID: 30447399
[TBL] [Abstract][Full Text] [Related]
22. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H
Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302
[TBL] [Abstract][Full Text] [Related]
23. Prodrug strategy for PSMA-targeted delivery of TGX-221 to prostate cancer cells.
Zhao Y; Duan S; Zeng X; Liu C; Davies NM; Li B; Forrest ML
Mol Pharm; 2012 Jun; 9(6):1705-16. PubMed ID: 22494444
[TBL] [Abstract][Full Text] [Related]
24. Novel polymeric micelles as enzyme-sensitive nuclear-targeted dual-functional drug delivery vehicles for enhanced 9-nitro-20(S)-camptothecin delivery and antitumor efficacy.
Sun Y; Liang Y; Hao N; Fu X; He B; Han S; Cao J; Ma Q; Xu W; Sun Y
Nanoscale; 2020 Mar; 12(9):5380-5396. PubMed ID: 32022069
[TBL] [Abstract][Full Text] [Related]
25. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice.
Luan X; Rahme K; Cong Z; Wang L; Zou Y; He Y; Yang H; Holmes JD; O'Driscoll CM; Guo J
Eur J Pharm Biopharm; 2019 Apr; 137():56-67. PubMed ID: 30779980
[TBL] [Abstract][Full Text] [Related]
26. Biodegradable brush-type copolymer modified with targeting peptide as a nanoscopic platform for targeting drug delivery to treat castration-resistant prostate cancer.
Liu T; Huang Q
Int J Pharm; 2016 Sep; 511(2):1002-11. PubMed ID: 27521701
[TBL] [Abstract][Full Text] [Related]
27. Prostate-Specific Membrane Antigen Targeted Therapy of Prostate Cancer Using a DUPA-Paclitaxel Conjugate.
Lv Q; Yang J; Zhang R; Yang Z; Yang Z; Wang Y; Xu Y; He Z
Mol Pharm; 2018 May; 15(5):1842-1852. PubMed ID: 29608845
[TBL] [Abstract][Full Text] [Related]
28. A Novel Prostate-Specific Membrane-Antigen (PSMA) Targeted Micelle-Encapsulating Wogonin Inhibits Prostate Cancer Cell Proliferation via Inducing Intrinsic Apoptotic Pathway.
Zhang H; Liu X; Wu F; Qin F; Feng P; Xu T; Li X; Yang L
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196894
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and
Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Sadeghian-Rizi S
Anticancer Agents Med Chem; 2018; 18(14):2017-2031. PubMed ID: 30205803
[TBL] [Abstract][Full Text] [Related]
30. Actively targeted delivery of anticancer drug to tumor cells by redox-responsive star-shaped micelles.
Shi C; Guo X; Qu Q; Tang Z; Wang Y; Zhou S
Biomaterials; 2014 Oct; 35(30):8711-22. PubMed ID: 25002267
[TBL] [Abstract][Full Text] [Related]
31. A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy.
Lee SY; Yang CY; Peng CL; Wei MF; Chen KC; Yao CJ; Shieh MJ
Biomaterials; 2016 Apr; 86():92-105. PubMed ID: 26896610
[TBL] [Abstract][Full Text] [Related]
32. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
33. Reducible self-assembling cationic polypeptide-based micelles mediate co-delivery of doxorubicin and microRNA-34a for androgen-independent prostate cancer therapy.
Yao C; Liu J; Wu X; Tai Z; Gao Y; Zhu Q; Li J; Zhang L; Hu C; Gu F; Gao J; Gao S
J Control Release; 2016 Jun; 232():203-14. PubMed ID: 27126903
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
[TBL] [Abstract][Full Text] [Related]
35. Cell-Penetrating Peptide Modified PEG-PLA Micelles for Efficient PTX Delivery.
Shuai Q; Cai Y; Zhao G; Sun X
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182734
[TBL] [Abstract][Full Text] [Related]
36. Drug-interactive mPEG-
Gong F; Wang R; Zhu Z; Duan J; Teng X; Cui ZK
Drug Deliv; 2020 Dec; 27(1):238-247. PubMed ID: 32003299
[TBL] [Abstract][Full Text] [Related]
37. Targeted delivery of ginsenoside compound K using TPGS/PEG-PCL mixed micelles for effective treatment of lung cancer.
Yang L; Zhang Z; Hou J; Jin X; Ke Z; Liu D; Du M; Jia X; Lv H
Int J Nanomedicine; 2017; 12():7653-7667. PubMed ID: 29089761
[TBL] [Abstract][Full Text] [Related]
38. Cell-selective gene silencing in prostate cancer LNCap cells using prostate-specific membrane antigen promoter and enhancer in vitro and in vivo.
Liu R; Sun J; Zhang Z; Xu Y
Cell Biol Int; 2012 Oct; 36(10):863-72. PubMed ID: 22612256
[TBL] [Abstract][Full Text] [Related]
39. Treating colon cancer with a suicide gene delivered by self-assembled cationic MPEG-PCL micelles.
Duan X; Wang P; Men K; Gao X; Huang M; Gou M; Chen L; Qian Z; Wei Y
Nanoscale; 2012 Apr; 4(7):2400-7. PubMed ID: 22388488
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and in vivo delivery of curcumin by copolymeric mPEG-PCL micelles.
Kheiri Manjili H; Ghasemi P; Malvandi H; Mousavi MS; Attari E; Danafar H
Eur J Pharm Biopharm; 2017 Jul; 116():17-30. PubMed ID: 27756682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
